human lymph node st dataset Search Results


90
10X Genomics human lymph node spatial dataset
Comprehensive single‐cell RNA sequencing strategy to characterize major <t>lymph</t> <t>node</t> stromal cell (LNSC) populations. (a) Overview of the experimental pipeline used in this study. The process begins with the enzymatic digestion of a <t>human</t> lymph node to generate a single‐cell suspension, which is then subjected to cell sorting and sequencing using the 10× Chromium platform. The resulting data is analyzed to produce a UMAP (Uniform Manifold Approximation and Projection) representation, which clusters the cells based on their gene expression profiles. These clusters are then mapped back to their <t>spatial</t> locations within the lymph node tissue using spatial transcriptomics, providing a physical localization of the different fibroblast subsets. Finally, multiplexed imaging microscopy is used to validate the physical location of these subsets within the lymph node using a fluorescent microscope. (b) Flow cytometry gating strategy used to sort viable CD45‐ CD235a‐ single cells containing DN, FRC, LEC, and BEC (see Figure for more details). (c) Two‐dimensional clustering of 9267 LNSCs analyzed by scRNA‐seq. LNSCs are color‐coded based on their main phenotype: fibroblasts (red), LEC (blue), and BEC (green). (d) Pie chart illustrating the proportional distribution of each LNSC phenotype among the total 9267 cells analyzed. This chart provides a quantitative overview of the relative abundance of fibroblasts, LEC, and BEC in the sample. (e) Violin plots showing the log‐normalized expression levels of marker genes specific to each LNSC phenotype. For endothelial cells (BEC and LEC), PECAM1 and VWF are used as markers; for fibroblasts (FRC), DCN, LUM, and PDGFRB are shown; and for LEC, PROX1 and LYVE1 are the defining marker. (f) Heatmap depicting the top 50 differentially expressed genes across the three main LNSC populations at the single‐cell level. Marker genes are highlighted within the heatmap, and the bars at the top of the heatmap correspond to the different LNSC phenotypes (red for fibroblasts, blue for LEC, and green for BEC). Z‐scores are shown to indicate fold‐change expression relative to the mean expression for each gene.
Human Lymph Node Spatial Dataset, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lymph+node+st+dataset/human+lymph+node+spatial+dataset/pmc12154172-254-1-17
Average 90 stars, based on 1 article reviews
human lymph node spatial dataset - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Mendeley Ltd human lymph node imc datasets
a , Experimental workflow to compare the results of spatial transcriptomic and <t>IMC</t> large-scale analysis. b , Left, number of recovered clusters versus number of sampled regions for IMC lymph node data from sample no. 1. Each point corresponds to the mean number of recovered clusters across 50 similar simulations and vertical bars correspond to the standard error. The red dashed line corresponds to the fitted function. The horizontal dashed lines correspond to the number of observed clusters ( N o ; blue) and the actual number of clusters ( N total ; gray). Middle, number of recovered clusters versus number of sampled regions for FoVs ranging from 200 to 500 µm for the IMC lymph node data from sample no. 1. Each point corresponds to the mean number of recovered clusters across 50 similar simulations and vertical bars correspond to the standard error. The red dashed lines correspond to individual fits for each w value. Right, relationship between τ and w for the IMC lymph node data from sample no. 1. The dashed line corresponds to the linear regression after log 10 transform. c , Left, values of τ for 400-µm width FoV for the Visium and <t>IMC</t> <t>datasets</t> for lymph node samples. Middle, values of α for the lymph node datasets. Right, values of C for the lymph node datasets. d , Comparison of α values between the IMC breast cancer dataset ( n = 39 FoVs) and the five Visium breast cancer datasets ( n = 5 samples). The P value was computed using a two-sided Mann–Whitney rank test. Large bars correspond to the median and small bars to the IQR. e , Estimation of sampling strategy efficiency for breast cancer (left) and heart (right) Visium samples. The dashed lines correspond to the possible values taken for a fixed area surface. f , Proportions of recovered clusters when the area imaged (indicated by solid, dashed or dotted lines) was fragmented for breast cancer (red lines) and heart (blue lines) datasets. Source data for this figure are provided.
Human Lymph Node Imc Datasets, supplied by Mendeley Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lymph+node+st+dataset/human+lymph+node+imc+datasets/pmc09998266-249-3-16
Average 90 stars, based on 1 article reviews
human lymph node imc datasets - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
10X Genomics visium human lymph node
a , Experimental workflow to compare the results of spatial transcriptomic and <t>IMC</t> large-scale analysis. b , Left, number of recovered clusters versus number of sampled regions for IMC lymph node data from sample no. 1. Each point corresponds to the mean number of recovered clusters across 50 similar simulations and vertical bars correspond to the standard error. The red dashed line corresponds to the fitted function. The horizontal dashed lines correspond to the number of observed clusters ( N o ; blue) and the actual number of clusters ( N total ; gray). Middle, number of recovered clusters versus number of sampled regions for FoVs ranging from 200 to 500 µm for the IMC lymph node data from sample no. 1. Each point corresponds to the mean number of recovered clusters across 50 similar simulations and vertical bars correspond to the standard error. The red dashed lines correspond to individual fits for each w value. Right, relationship between τ and w for the IMC lymph node data from sample no. 1. The dashed line corresponds to the linear regression after log 10 transform. c , Left, values of τ for 400-µm width FoV for the Visium and <t>IMC</t> <t>datasets</t> for lymph node samples. Middle, values of α for the lymph node datasets. Right, values of C for the lymph node datasets. d , Comparison of α values between the IMC breast cancer dataset ( n = 39 FoVs) and the five Visium breast cancer datasets ( n = 5 samples). The P value was computed using a two-sided Mann–Whitney rank test. Large bars correspond to the median and small bars to the IQR. e , Estimation of sampling strategy efficiency for breast cancer (left) and heart (right) Visium samples. The dashed lines correspond to the possible values taken for a fixed area surface. f , Proportions of recovered clusters when the area imaged (indicated by solid, dashed or dotted lines) was fragmented for breast cancer (red lines) and heart (blue lines) datasets. Source data for this figure are provided.
Visium Human Lymph Node, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lymph+node+st+dataset/visium+human+lymph+node+datasets/pmc10463137-43-0-7
Average 90 stars, based on 1 article reviews
visium human lymph node - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Comprehensive single‐cell RNA sequencing strategy to characterize major lymph node stromal cell (LNSC) populations. (a) Overview of the experimental pipeline used in this study. The process begins with the enzymatic digestion of a human lymph node to generate a single‐cell suspension, which is then subjected to cell sorting and sequencing using the 10× Chromium platform. The resulting data is analyzed to produce a UMAP (Uniform Manifold Approximation and Projection) representation, which clusters the cells based on their gene expression profiles. These clusters are then mapped back to their spatial locations within the lymph node tissue using spatial transcriptomics, providing a physical localization of the different fibroblast subsets. Finally, multiplexed imaging microscopy is used to validate the physical location of these subsets within the lymph node using a fluorescent microscope. (b) Flow cytometry gating strategy used to sort viable CD45‐ CD235a‐ single cells containing DN, FRC, LEC, and BEC (see Figure for more details). (c) Two‐dimensional clustering of 9267 LNSCs analyzed by scRNA‐seq. LNSCs are color‐coded based on their main phenotype: fibroblasts (red), LEC (blue), and BEC (green). (d) Pie chart illustrating the proportional distribution of each LNSC phenotype among the total 9267 cells analyzed. This chart provides a quantitative overview of the relative abundance of fibroblasts, LEC, and BEC in the sample. (e) Violin plots showing the log‐normalized expression levels of marker genes specific to each LNSC phenotype. For endothelial cells (BEC and LEC), PECAM1 and VWF are used as markers; for fibroblasts (FRC), DCN, LUM, and PDGFRB are shown; and for LEC, PROX1 and LYVE1 are the defining marker. (f) Heatmap depicting the top 50 differentially expressed genes across the three main LNSC populations at the single‐cell level. Marker genes are highlighted within the heatmap, and the bars at the top of the heatmap correspond to the different LNSC phenotypes (red for fibroblasts, blue for LEC, and green for BEC). Z‐scores are shown to indicate fold‐change expression relative to the mean expression for each gene.

Journal: European Journal of Immunology

Article Title: Identification and Mapping of Human Lymph Node Stromal Cell Subsets by Combining Single‐Cell RNA Sequencing with Spatial Transcriptomics

doi: 10.1002/eji.202451218

Figure Lengend Snippet: Comprehensive single‐cell RNA sequencing strategy to characterize major lymph node stromal cell (LNSC) populations. (a) Overview of the experimental pipeline used in this study. The process begins with the enzymatic digestion of a human lymph node to generate a single‐cell suspension, which is then subjected to cell sorting and sequencing using the 10× Chromium platform. The resulting data is analyzed to produce a UMAP (Uniform Manifold Approximation and Projection) representation, which clusters the cells based on their gene expression profiles. These clusters are then mapped back to their spatial locations within the lymph node tissue using spatial transcriptomics, providing a physical localization of the different fibroblast subsets. Finally, multiplexed imaging microscopy is used to validate the physical location of these subsets within the lymph node using a fluorescent microscope. (b) Flow cytometry gating strategy used to sort viable CD45‐ CD235a‐ single cells containing DN, FRC, LEC, and BEC (see Figure for more details). (c) Two‐dimensional clustering of 9267 LNSCs analyzed by scRNA‐seq. LNSCs are color‐coded based on their main phenotype: fibroblasts (red), LEC (blue), and BEC (green). (d) Pie chart illustrating the proportional distribution of each LNSC phenotype among the total 9267 cells analyzed. This chart provides a quantitative overview of the relative abundance of fibroblasts, LEC, and BEC in the sample. (e) Violin plots showing the log‐normalized expression levels of marker genes specific to each LNSC phenotype. For endothelial cells (BEC and LEC), PECAM1 and VWF are used as markers; for fibroblasts (FRC), DCN, LUM, and PDGFRB are shown; and for LEC, PROX1 and LYVE1 are the defining marker. (f) Heatmap depicting the top 50 differentially expressed genes across the three main LNSC populations at the single‐cell level. Marker genes are highlighted within the heatmap, and the bars at the top of the heatmap correspond to the different LNSC phenotypes (red for fibroblasts, blue for LEC, and green for BEC). Z‐scores are shown to indicate fold‐change expression relative to the mean expression for each gene.

Article Snippet: The human lymph node spatial dataset was downloaded from the dataset portal provided by 10× Genomics ( https://support.10xgenomics.com/spatial‐gene‐expression/datasets/1.1.0/V1_Human_Lymph_Node ).

Techniques: RNA Sequencing, Suspension, FACS, Sequencing, Gene Expression, Imaging, Microscopy, Flow Cytometry, Expressing, Marker

Identification and characterization of 10 lymph node fibroblast subsets via single‐cell RNA sequencing. (a) UMAP (Uniform Manifold Approximation and Projection) analysis depicting 10 distinct clusters of lymph node fibroblasts. Each cluster represents a subset of fibroblasts with a unique transcriptional profile. Cells are color‐coded according to the cluster to which they belong. (b) Bar plot displaying the absolute number of cells within each of the 10 fibroblast clusters. Each bar is colored to correspond with the UMAP clusters, providing a quantitative overview of the relative abundance of each fibroblast subset. (c) Heatmap showing per cell (column) the expression patterns of the top 50 DEGs (rows) across the 10 fibroblast clusters. Each column represents a single cell, while rows correspond to specific DEGs. Marker genes defining each fibroblast cluster are highlighted on the left, and the Z‐score normalized expression levels are indicated by the color legend on the right. The top of the heatmap includes color‐coded bars representing the assigned cluster for each fibroblast. (d) Violin plots showing Z‐score expression levels of key marker genes for each fibroblast cluster. (e) Gene Ontology (GO) enrichment analysis was conducted on the DEGs identified in each fibroblast cluster. The analysis highlights the top three GO molecular functions for each subset. (f) Integrated scRNA‐seq analysis of LN fibroblasts by combining our dataset with two publicly available datasets of Abe et al. and Kapoor et al. . UMAP visualization illustrates the distribution of cell subsets across the integrated dataset, comprising 42,073 lymph node cells isolated from a total of 13 donors. The integrated analysis reveals the consistency of the fibroblast clusters across different datasets. (g) This stacked bar plot shows the percentage distribution of cell clusters within three integrated datasets: Abe et al. , Grasso et al., and Kapoor et al. . Each bar represents one dataset ( x ‐axis), and the different colors within each bar correspond to specific clusters (0–11), as indicated in the legend on the right. The y ‐axis represents the fraction of cells within each dataset, ranging from 0.0 to 1.0, with 1.0 indicating 100% of cells within a dataset.

Journal: European Journal of Immunology

Article Title: Identification and Mapping of Human Lymph Node Stromal Cell Subsets by Combining Single‐Cell RNA Sequencing with Spatial Transcriptomics

doi: 10.1002/eji.202451218

Figure Lengend Snippet: Identification and characterization of 10 lymph node fibroblast subsets via single‐cell RNA sequencing. (a) UMAP (Uniform Manifold Approximation and Projection) analysis depicting 10 distinct clusters of lymph node fibroblasts. Each cluster represents a subset of fibroblasts with a unique transcriptional profile. Cells are color‐coded according to the cluster to which they belong. (b) Bar plot displaying the absolute number of cells within each of the 10 fibroblast clusters. Each bar is colored to correspond with the UMAP clusters, providing a quantitative overview of the relative abundance of each fibroblast subset. (c) Heatmap showing per cell (column) the expression patterns of the top 50 DEGs (rows) across the 10 fibroblast clusters. Each column represents a single cell, while rows correspond to specific DEGs. Marker genes defining each fibroblast cluster are highlighted on the left, and the Z‐score normalized expression levels are indicated by the color legend on the right. The top of the heatmap includes color‐coded bars representing the assigned cluster for each fibroblast. (d) Violin plots showing Z‐score expression levels of key marker genes for each fibroblast cluster. (e) Gene Ontology (GO) enrichment analysis was conducted on the DEGs identified in each fibroblast cluster. The analysis highlights the top three GO molecular functions for each subset. (f) Integrated scRNA‐seq analysis of LN fibroblasts by combining our dataset with two publicly available datasets of Abe et al. and Kapoor et al. . UMAP visualization illustrates the distribution of cell subsets across the integrated dataset, comprising 42,073 lymph node cells isolated from a total of 13 donors. The integrated analysis reveals the consistency of the fibroblast clusters across different datasets. (g) This stacked bar plot shows the percentage distribution of cell clusters within three integrated datasets: Abe et al. , Grasso et al., and Kapoor et al. . Each bar represents one dataset ( x ‐axis), and the different colors within each bar correspond to specific clusters (0–11), as indicated in the legend on the right. The y ‐axis represents the fraction of cells within each dataset, ranging from 0.0 to 1.0, with 1.0 indicating 100% of cells within a dataset.

Article Snippet: The human lymph node spatial dataset was downloaded from the dataset portal provided by 10× Genomics ( https://support.10xgenomics.com/spatial‐gene‐expression/datasets/1.1.0/V1_Human_Lymph_Node ).

Techniques: RNA Sequencing, Expressing, Marker, Isolation

Spatial distribution of fibroblast subsets within the lymph node revealed by spatial transcriptomics and microscopy. (a) On the left, a histological section of a human lymph node stained with hematoxylin and eosin (H&E), highlighting the structural components of the lymph node, such as follicles, germinal centers, and medullary areas. The image is adapted from 10× Genomics. On the right, spatial gene expression profiles corresponding to the same histological section, reveal distinct regions such as germinal centers, follicles, T‐ and B‐cell areas, medulla, blood vessels, and lymphatic vessels. Each region is color‐coded (see legend) to illustrate its spatial distribution (see also Figure for more details on the analysis). (b) Heatmap showing the differentially expressed genes (DEGs) used to define and annotate the major regions of the lymph node. The color‐coded bars correspond to each region, with Z‐scores on the right representing the relative gene expression levels across these regions. (C–N) Spatial maps displaying in‐silico prediction scores for the presence of each fibroblast subset at various locations within the lymph node. Prediction scores range from 0 (blue, indicating no predicted presence) to 1 (red, indicating a high likelihood of presence). (O) Two‐dimensional heatmap showing the clustering of mean prediction scores per area of the lymph node for each fibroblast subset. The mean prediction values were grouped into low, medium, and high scores, indicating the likely abundance of each fibroblast subset across different regions of the lymph node. (P) Composite immunofluorescence micrographs (acquired at 40× magnification) of a human lymph node section. Specific markers, including CD31 (green), CD34 (magenta), PDPN (yellow), and CD19 (cyan), are displayed in individual panels, and the “Merge” panel combines the staining patterns of CD31, CD34, and PDPN to reveal co‐localization. The “Merge + Sytox Blue” panel adds a nuclear counterstain. Inserts in the micrographs magnify regions of particular interest, with arrows indicating co‐localization of specific markers. Scale bars are 20 µm for individual panels and inserts, and 100 µm for the full section. Representative images from one of three different lymph nodes are shown. (Q) Immunofluorescence staining of another human lymph node section, (acquired at 40× magnification), showing the distribution of markers CD21L (magenta), GLDN (green), PDPN (yellow), and CD19 (cyan) within the tissue architecture. The full section (leftmost panel) illustrates the spatial localization of these markers. The upper and lower rows of magnified inserts focus on two distinct areas of interest within the lymph node. Individual panels provide detailed views of each marker, while the final panel merges all the markers along with Sytox Blue as a nuclear counterstain. Scale bars are 20 µm for individual panels and inserts, and 100 µm for the full section. Representative images from one of three different lymph nodes are shown.

Journal: European Journal of Immunology

Article Title: Identification and Mapping of Human Lymph Node Stromal Cell Subsets by Combining Single‐Cell RNA Sequencing with Spatial Transcriptomics

doi: 10.1002/eji.202451218

Figure Lengend Snippet: Spatial distribution of fibroblast subsets within the lymph node revealed by spatial transcriptomics and microscopy. (a) On the left, a histological section of a human lymph node stained with hematoxylin and eosin (H&E), highlighting the structural components of the lymph node, such as follicles, germinal centers, and medullary areas. The image is adapted from 10× Genomics. On the right, spatial gene expression profiles corresponding to the same histological section, reveal distinct regions such as germinal centers, follicles, T‐ and B‐cell areas, medulla, blood vessels, and lymphatic vessels. Each region is color‐coded (see legend) to illustrate its spatial distribution (see also Figure for more details on the analysis). (b) Heatmap showing the differentially expressed genes (DEGs) used to define and annotate the major regions of the lymph node. The color‐coded bars correspond to each region, with Z‐scores on the right representing the relative gene expression levels across these regions. (C–N) Spatial maps displaying in‐silico prediction scores for the presence of each fibroblast subset at various locations within the lymph node. Prediction scores range from 0 (blue, indicating no predicted presence) to 1 (red, indicating a high likelihood of presence). (O) Two‐dimensional heatmap showing the clustering of mean prediction scores per area of the lymph node for each fibroblast subset. The mean prediction values were grouped into low, medium, and high scores, indicating the likely abundance of each fibroblast subset across different regions of the lymph node. (P) Composite immunofluorescence micrographs (acquired at 40× magnification) of a human lymph node section. Specific markers, including CD31 (green), CD34 (magenta), PDPN (yellow), and CD19 (cyan), are displayed in individual panels, and the “Merge” panel combines the staining patterns of CD31, CD34, and PDPN to reveal co‐localization. The “Merge + Sytox Blue” panel adds a nuclear counterstain. Inserts in the micrographs magnify regions of particular interest, with arrows indicating co‐localization of specific markers. Scale bars are 20 µm for individual panels and inserts, and 100 µm for the full section. Representative images from one of three different lymph nodes are shown. (Q) Immunofluorescence staining of another human lymph node section, (acquired at 40× magnification), showing the distribution of markers CD21L (magenta), GLDN (green), PDPN (yellow), and CD19 (cyan) within the tissue architecture. The full section (leftmost panel) illustrates the spatial localization of these markers. The upper and lower rows of magnified inserts focus on two distinct areas of interest within the lymph node. Individual panels provide detailed views of each marker, while the final panel merges all the markers along with Sytox Blue as a nuclear counterstain. Scale bars are 20 µm for individual panels and inserts, and 100 µm for the full section. Representative images from one of three different lymph nodes are shown.

Article Snippet: The human lymph node spatial dataset was downloaded from the dataset portal provided by 10× Genomics ( https://support.10xgenomics.com/spatial‐gene‐expression/datasets/1.1.0/V1_Human_Lymph_Node ).

Techniques: Microscopy, Staining, Gene Expression, In Silico, Immunofluorescence, Marker

a , Experimental workflow to compare the results of spatial transcriptomic and IMC large-scale analysis. b , Left, number of recovered clusters versus number of sampled regions for IMC lymph node data from sample no. 1. Each point corresponds to the mean number of recovered clusters across 50 similar simulations and vertical bars correspond to the standard error. The red dashed line corresponds to the fitted function. The horizontal dashed lines correspond to the number of observed clusters ( N o ; blue) and the actual number of clusters ( N total ; gray). Middle, number of recovered clusters versus number of sampled regions for FoVs ranging from 200 to 500 µm for the IMC lymph node data from sample no. 1. Each point corresponds to the mean number of recovered clusters across 50 similar simulations and vertical bars correspond to the standard error. The red dashed lines correspond to individual fits for each w value. Right, relationship between τ and w for the IMC lymph node data from sample no. 1. The dashed line corresponds to the linear regression after log 10 transform. c , Left, values of τ for 400-µm width FoV for the Visium and IMC datasets for lymph node samples. Middle, values of α for the lymph node datasets. Right, values of C for the lymph node datasets. d , Comparison of α values between the IMC breast cancer dataset ( n = 39 FoVs) and the five Visium breast cancer datasets ( n = 5 samples). The P value was computed using a two-sided Mann–Whitney rank test. Large bars correspond to the median and small bars to the IQR. e , Estimation of sampling strategy efficiency for breast cancer (left) and heart (right) Visium samples. The dashed lines correspond to the possible values taken for a fixed area surface. f , Proportions of recovered clusters when the area imaged (indicated by solid, dashed or dotted lines) was fragmented for breast cancer (red lines) and heart (blue lines) datasets. Source data for this figure are provided.

Journal: Nature Methods

Article Title: Optimizing multiplexed imaging experimental design through tissue spatial segregation estimation

doi: 10.1038/s41592-022-01692-z

Figure Lengend Snippet: a , Experimental workflow to compare the results of spatial transcriptomic and IMC large-scale analysis. b , Left, number of recovered clusters versus number of sampled regions for IMC lymph node data from sample no. 1. Each point corresponds to the mean number of recovered clusters across 50 similar simulations and vertical bars correspond to the standard error. The red dashed line corresponds to the fitted function. The horizontal dashed lines correspond to the number of observed clusters ( N o ; blue) and the actual number of clusters ( N total ; gray). Middle, number of recovered clusters versus number of sampled regions for FoVs ranging from 200 to 500 µm for the IMC lymph node data from sample no. 1. Each point corresponds to the mean number of recovered clusters across 50 similar simulations and vertical bars correspond to the standard error. The red dashed lines correspond to individual fits for each w value. Right, relationship between τ and w for the IMC lymph node data from sample no. 1. The dashed line corresponds to the linear regression after log 10 transform. c , Left, values of τ for 400-µm width FoV for the Visium and IMC datasets for lymph node samples. Middle, values of α for the lymph node datasets. Right, values of C for the lymph node datasets. d , Comparison of α values between the IMC breast cancer dataset ( n = 39 FoVs) and the five Visium breast cancer datasets ( n = 5 samples). The P value was computed using a two-sided Mann–Whitney rank test. Large bars correspond to the median and small bars to the IQR. e , Estimation of sampling strategy efficiency for breast cancer (left) and heart (right) Visium samples. The dashed lines correspond to the possible values taken for a fixed area surface. f , Proportions of recovered clusters when the area imaged (indicated by solid, dashed or dotted lines) was fragmented for breast cancer (red lines) and heart (blue lines) datasets. Source data for this figure are provided.

Article Snippet: Raw and processed human lymph node IMC datasets generated for this article are freely available on Mendeley ( https://data.mendeley.com/datasets/ncfgz5xxyb/1 ).

Techniques: Comparison, MANN-WHITNEY, Sampling